Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study

Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England

(2022) T. Beaney et al.   Nature Communications

Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure

(2022) Catherine J. Reynolds et al.   SCIENCE

Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes

(2022) Dan-Yu Lin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers

(2021) Sheila F Lumley et al.   CLINICAL INFECTIOUS DISEASES

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

(2021) Jan Van Elslande et al.   JOURNAL OF CLINICAL VIROLOGY

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses

(2021) Natalia Ortega et al.   Nature Communications

Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset

(2020) Bin Lou et al.   EUROPEAN RESPIRATORY JOURNAL

Kinetics of viral load and antibody response in relation to COVID-19 severity

(2020) Yanqun Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

(2020) Mark Ainsworth et al.   LANCET INFECTIOUS DISEASES

Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients

(2020) Yanan Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY